Koninklijke Philips N.V.

PHG Healthcare Medical Devices

Koninklijke Philips N.V.’s revenue for fiscal 2025 (year ended December 2025) was $20.2 billion, up 3.47% from fiscal 2024.

Revenue
+0.55%
EPS
−85.0%
Free cash flow
+154.2%
Total debt
−4.96%

Quarter to September 2026, against a year earlier

30.41 0.10 −0.33%
Market cap
$29.8B
P/E
25.8×
Fwd P/E
11.2×
Dividend yield
3.33%
F-score
7/9
Altman Z
1.98
Beneish M
−2.68
Dividend safety
55/100

Koninklijke Philips N.V. (PHG) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, Koninklijke Philips N.V. (PHG) trades at a EV/Sales of 1.7×. Over the past ten years it has ranged from 0.7× (November 2022) to 2.0× (September 2018); the current reading is higher than 81% of that period. That is below the Medical Devices industry median of 2.7× and below the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 1.5× (0.88%)
FY2024 1.5× 35.80%
FY2023 1.1× 32.33%
FY2022 0.8× (41.21%)
FY2021 1.4× (18.27%)
FY2020 1.8× 30.40%
FY2019 1.3× 17.15%
FY2018 1.1× (29.58%)
FY2017 1.6× 62.03%
FY2016 1.0× 5.04%

Quarterly newest first

Period EV/Sales Change
Sep 2026 1.4× (8.06%)
Jun 2026 1.5× (0.20%)
Mar 2026 1.5× 1.19%
Dec 2025 1.5× (10.68%)
37 more quarters

Against its own ten years

Low 0.7× High 2.0×
Ten-year median 1.4×
Current reading's percentile 80

EV/Sales against peers

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on PHG